• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Public Workshop: Adjuvants and Adjuvanted Preventative and Therapeutic Vaccines for Infectious Disease Indications

December 2 – 3, 2008

The Food and Drug Administration (FDA), in cooperation with the National Institutes of Health (NIH), is announcing a workshop on Adjuvants and Adjuvanted vaccines. This is a 2-day workshop for academics, government researchers, government regulators, vaccine clinical trial experts and industry representatives. The purpose of this workshop is to assess the scientific knowledge base regarding vaccine adjuvants and to facilitate the development of a research agenda to improve the safety and efficacy assessments of adjuvanted vaccines for the treatment and prevention of disease.

Printable Version: Workshop Agenda (PDF - 44 KB)

December 2, 2008
Printable Version: Workshop Transcript Day 1 (PDF - 8 MB)

December 3, 2008
Printable Version: Workshop Transcript Day 2 (PDF - 1 MB)

Location

Bethesda North Marriot and Conference Center
5701 Marinelli Road
Rockville, MD 20852
(800) 859-8003

Contact

Nicolette deVore
CBER/FDA
301-496-4861
e-mail: nicolette.devore@fda.hhs.gov